Medsintez Plant is a modern full-cycle biotechnological enterprise for development and production of pharmaceutical products. The Medsintez Plant has been present on the Russian market for 20 years and is an active participant of drug import substitution programs in the Russian Federation.

According to the Russian and international GMP, ISO 9001:2015 standards, the production buildings are zoned by clean grades; the transportation of raw materials, personnel, half-finished and finished products has been organized.

The Government of the Russian Federation included the Medsintez Plant in the list of systemic enterprises of Russia in accordance with the protocol (No. 13-KZ dated 19/6/2020).

In 2025, Medsintez Plant was among the leading companies awarded the status of National Champion based on the results of a comprehensive expert selection.

Today, the Medsintez Plant addresses systemic challenges, such as mastering innovative technologies in line with international standards, expanding into the global market, developing the R&D center, creating IT solutions for pharmaceuticals and medical technologies, as well as providing ongoing personnel training and social support.